Corporate Development

Cubist Business Development

Cubist Pharmaceuticals is a leader in the development and commercialization of acute care drugs for the treatment of unmet medical needs. With a proven track record of success in antibiotics, Cubist has the Clinical, Regulatory and Commercial capacity and expertise to acquire, develop and commercialize pharmaceutical products at any stage of research and development. The Business Development strategy focuses on novel therapeutics (including small molecules, proteins, and antibodies) at any stage of research or development that are consistent with the company's commercial strength in the hospital environment.

To discuss opportunities with Cubist Pharmaceuticals, the Business Development Team recommends that potential collaborators provide a detailed non-confidential package describing the opportunity, including supporting scientific data.

Please forward your requests to:

Email: bd@cubist.com

Or via mail:

    Business Development
Cubist Pharmaceuticals, Inc.
65 Hayden Avenue
Lexington, Massachusetts 02421
Tel: 781.860.8660
Fax: 781.860.1194
    

Who we are:

Praveen Tipirneni, MD, Vice President
Aaron Pelta, Senior Manager
Steven Luperchio, PhD, Senior Manager
Heinrich Schlieker, PhD, Director
Athena Marken, Business Development Assistant